31(top 2%)
papers
1.7K(top 1%)
citations
21(top 1%)
h-index
30(top 2%)
g-index
31
all documents
1.9K
doc citations
560
citing journals

Top Articles

#TitleJournalYearCitations
1Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNetBlood2019393
2ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphomaAnnals of Oncology2013268
3How I treat chronic myelomonocytic leukemiaBlood201793
4Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in AdultsHemaSphere201891
5Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemiaLeukemia201686
6Luspatercept for the treatment of anemia in myelodysplastic syndromes and primary myelofibrosisBlood201975
7Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating AgentsEBioMedicine201872
8MRD assessed byWT1andNPM1transcript levels identifies distinct outcomes in AML patients and is influenced by gemtuzumab ozogamicinOncotarget201471
9Impact of Inhaled Nitric Oxide on Platelet Aggregation and Fibrinolysis in Rats with Endotoxic Lung InjuryAmerican Journal of Respiratory and Critical Care Medicine199867
10Impact of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemiaBlood201766
11Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemiaLeukemia201966
12Clonal interference of signaling mutations worsens prognosis in core-binding factor acute myeloid leukemiaBlood201854
13Blinatumomab compared with standard of care for the treatment of adult patients with relapsed/refractory Philadelphia chromosome–positive B‐precursor acute lymphoblastic leukemiaCancer202049
14New Treatment Options for Acute Myeloid Leukemia in 2019Current Oncology Reports201949
15Obinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSABlood202148
16Epidemiology of invasive fungal infections during induction therapy in adults with acute lymphoblastic leukemia: a GRAALL-2005 studyLeukemia and Lymphoma201747
17Hypomethylating Agents as a Therapy for AMLCurrent Hematologic Malignancy Reports201747
18Pediatric-Like Therapy for Adults with ALLCurrent Hematologic Malignancy Reports201440
19Pre-treatment with oral hydroxyurea prior to intensive chemotherapy improves early survival of patients with high hyperleukocytosis in acute myeloid leukemiaLeukemia and Lymphoma201635
20Copy-number analysis identified new prognostic marker in acute myeloid leukemiaLeukemia201734
21Adult T-type lymphoblastic lymphoma: Treatment advances and prognostic indicatorsExperimental Hematology201729
22Dyserythropoiesis evaluated by the RED score and hepcidin:ferritin ratio predicts response to erythropoietin in lower-risk myelodysplastic syndromesHaematologica201917
23Cytokine-like protein 1–induced survival of monocytes suggests a combined strategy targeting MCL1 and MAPK in CMMLBlood202116
24Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French‐Belgian‐Swiss APL groupCancer201515
25Predictive value of 18F-FDG PET/CT in adults with T-cell lymphoblastic lymphoma: post hoc analysis of results from the GRAALL-LYSA LLO3 trialEuropean Journal of Nuclear Medicine and Molecular Imaging201715
26Cellular immune parameters associated with spontaneous control of CMV in children who underwent transplantationBone Marrow Transplantation201012
27A prospective registration study to determine feasibility of hematopoietic SCT in adults with acute leukemia: planning, expectations and realityBone Marrow Transplantation20148
28Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 YearsCancers20217
29Management of relapsed or refractory follicular lymphoma patients in daily practice – a French non-interventional studyLeukemia and Lymphoma20182
30PET-guided, BEACOPPescalated therapy in advanced Hodgkin lymphoma – Authors' replyLancet Oncology, The20192
31S1614 CHROMOSOMAL ABNORMALITIES DETERMINE OUTCOME IN NPM1MUT/FLT3-ITDNEG/LOW ACUTE MYELOID LEUKEMIAHemaSphere20190